Abstract
Altered
redox
homeostasis
has
long
been
observed
in
cancer
cells,
which
can
be
exploited
for
therapeutic
benefits.
However,
reactive
oxygen
species
(ROS)
pleiotropy
coupling
with
reductive
adaptation
cells
poses
a
formidable
challenge
dyshomeostasis‐based
therapy.
Herein,
AuPd
alloying
nanozyme‐glutathione
(GSH)
biosynthesis
inhibitor
co‐delivery
system
(B‐BMES)
is
developed
using
dendritic
SiO
2
as
matrix
to
target
homeostasis.
By
optimizing
element
composition,
the
nanozyme
B‐BMES
exhibits
potent
peroxidase
(POD)‐like
activity
trigger
ROS
insults‐mediated
dyshomeostasis.
Such
POD
functionality
attributed
optimized
electronic
structure
and
catalytic
activity.
Simultaneously,
abrogates
by
exerting
its
molecule‐targeted
GSH
suppression,
thereby
achieving
dual‐disruption
on
Camouflaging
tumor‐homologous
cytomembrane,
hybrid
nanosystem
biological
stability
tumor‐targeting
ability
further
fabricated,
initiates
safe,
precise
disruption‐based
therapy
sensibilizes
standard
chemotherapy.
ABSTRACT
Active
learning
(AL)
is
a
powerful
method
for
accelerating
novel
materials
discovery
but
faces
huge
challenges
extracting
physical
meaning.
Herein,
we
novelly
apply
an
interpretable
AL
strategy
to
efficiently
optimize
the
photothermal
conversion
efficiency
(PCE)
of
carbon
dots
(CDs)
in
therapy
(PTT).
An
equivalent
value
(SHapley
Additive
exPlanations
[SHAP‐EV])
proposed
which
explicitly
quantifies
linear
contributions
experimental
variables
PCE,
derived
from
joint
SHAP
values.
The
SHAP‐EV,
with
R
2
0.960
correlated
feature's
SHAP,
integrated
into
utility
functions
enhance
evaluation
during
optimization.
Using
this
approach,
successfully
synthesized
iron‐doped
CDs
(Fe‐CDs)
PCE
exceeding
78.7%
after
only
16
trials
over
four
iterations.
This
achievement
significantly
advances
previously
low
values
typically
reported
CDs.
Furthermore,
Fe‐CDs
demonstrated
multienzyme‐like
activities,
could
respond
tumor
microenvironment
(TME).
In
vitro
and
vivo
experiments
demonstrate
that
ferroptosis
through
synergistic
PTT
chemodynamic
(CDT),
thereby
achieving
remarkable
antitumor
efficacy.
Our
offers
new
insights
bio‐functional
development
treatments.
Journal of Translational Medicine,
Год журнала:
2024,
Номер
22(1)
Опубликована: Ноя. 16, 2024
Since
the
discovery
of
Fe3O4
nanoparticles
with
enzyme-like
activity
in
2007,
nanozymes
have
emerged
as
a
promising
class
catalysts,
offering
advantages
such
high
catalytic
efficiency,
low
cost,
mild
reaction
conditions,
and
excellent
stability.
These
properties
make
highly
suitable
for
large-scale
production.
In
recent
years,
convergence
nanomedicine
nanocatalysis
has
highlighted
potential
diagnostic
therapeutic
applications,
particularly
tumor
therapy.
Despite
these
advancements,
clinical
translation
remains
hindered
by
lack
designs
tailored
to
specific
characteristics,
limiting
their
effectiveness
targeted
This
review
addresses
mechanisms
which
induce
cell
death
various
types
emphasizes
key
design
considerations
needed
enhance
potential.
By
identifying
challenges
opportunities
field,
this
study
aims
provide
foundation
future
nanozyme
development,
ultimately
contributing
more
precise
effective
cancer
treatments.
Advanced Healthcare Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 24, 2025
Abstract
Poor
prognosis
and
chemotherapy
response
stem
from
difficulties
in
precise
targeting
the
lack
of
effective
synergistic
treatments.
Nanozymes
show
promising
potential
tumor
chemodynamic
therapy
(CDT)
by
catalyzing
hydrogen
peroxide
(H₂O₂)
decomposition
glutathione
depletion
microenvironment
(TME).
However,
integrating
with
CDT
remains
challenging.
In
this
study,
a
porous
Fe/Cu
bimetallic
nanozyme
carrier
(FeCuNPs)
is
developed
for
co‐loading
humanized
3F8
anti‐GD2
disialoganglioside
antibody
(3F8)
novel
pyridazinone‐based
chemotherapeutic
agent
(IMB),
forming
nanoreactor
(3F8@FeCuNPs@IMB)
targeted
CDT.
The
responds
specifically
to
acidic
TME
as
primary
insurance,
allowing
controlled
release
IMB
at
site.
coating
on
surface
acts
secondary
minimizing
drug
leakage
during
delivery
process
ensuring
chemotherapy.
Furthermore,
FeCuNPs
act
peroxidase‐like
(POD)
oxidase‐like
(GSHOX)
enzymes,
hydroxyl
radical
(•OH)
generation
depleting
excess
GSH,
enhancing
results
vitro
vivo
indicate
that
dual
insurance
designed
3F8@FeCuNPs@IMB
offers
prospect
targeted,
precise,
combination
against
melanoma.
Advanced Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 16, 2025
Abstract
Producing
high‐purity
oxygen
(O
2
)
has
a
wide
range
of
applications
across
diverse
sectors,
such
as
medicine,
tunnel
construction,
the
chemical
industry,
and
fermentation.
However,
current
O
production
methods
are
burdened
by
complexity,
heavy
equipment,
high
energy
consumption,
limited
adaptability
to
harsh
environments.
Here,
address
this
grand
challenge,
de
novo
design
Ru‐doped
metal
hydroxide
is
proposed
serve
bioinspired
‐evolution
catalysts
with
proton‐coupled
electron
transfer
(PCET)
pathway
for
low‐energy,
environmentally
friendly,
cost‐effective,
portable
generation.
The
comprehensive
studies
confirm
that
lattice
H
species
in
Ru‐Co(OH)
x
‐based
catalyst
can
trigger
PCET
optimize
Ru‐oxygen
intermediates
interactions,
thus
ultimately
reducing
reaction
barriers
improving
activities
durabilities.
Consequently,
prepared
‐loaded
membrane
exhibit
rapid
long‐term
stable
capabilities.
Furthermore,
material
strategy
H‐species
shows
remarkable
universality
broad
hydroxides.
This
efficient,
portable,
cost‐effective
generation
technique
suggested
ensure
an
uninterrupted
supply
during
emergencies
regions
availability
or
air
pollution,
offering
significant
societal
benefits
applications.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(10), С. 4696 - 4696
Опубликована: Май 14, 2025
To
overcome
the
limitations
associated
with
chemically
synthesized
nanoparticles
in
cancer
therapy,
researchers
have
increasingly
focused
on
developing
superior
biocompatibility
and
prolonged
tumor
retention
using
biosynthetic
methods.
In
this
study,
we
first
identified
presence
of
calcium
peroxide
(CaO2
NPs)
blood
individuals
who
had
ingested
gluconate.
Furthermore,
dropwise
addition
gluconate
to
human
serum
resulted
spontaneous
self-assembly
CaO2
NPs.
Next,
following
tail
vein
injection
fluorescently
labeled
NPs
into
subcutaneous
tumor-bearing
nude
mice,
observed
that
exhibited
accumulation
at
sites
compared
other
organs
through
visible-light
imaging.
Immunofluorescence
staining
demonstrated
co-localized
vesicular
transport-associated
proteins,
such
as
PV-1
Caveolin-1,
well
albumin-binding-associated
protein
SPARC,
suggesting
their
transport
from
vessels
site
is
mediated
by
Caveolin-1-
SPARC-dependent
active
pathways.
Additionally,
analysis
various
normal
mice
injected
concentrations
significantly
higher
than
experimental
dose
showed
no
apparent
organ
damage.
Hemolysis
assays
indicated
hemolysis
occurred
only
300
µg/mL,
whereas
concentration
remained
below
threshold
detectable
hemolytic
activity.
a
mouse
model,
treatment
docetaxel-loaded
68.5%
reduction
volume
free
docetaxel
(DTX)
alone.
These
novel
excellent
biocompatibility,
site,
safety,
drug-loading
capability.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 19, 2025
Abstract
Melanoma
is
the
most
common
malignant
skin
tumor,
characterized
by
complexity,
invasiveness,
and
heterogeneity.
Conventional
therapies
often
yield
poor
outcomes,
posing
significant
clinical
challenges.
Here,
a
microneedle
(MN)
patch
that
integrates
nanozyme
traditional
Chinese
medicine
(TCM)
for
ferroptosis
pathway‐dependent
combined
therapy
of
melanoma
designed.
To
amplify
therapeutic
activity,
novel
Au@MoS
2
bimetallic
plasmonic
(BPNzyme)
prepared
through
simple
aqueous
synthesis
strategy
involving
two‐step
process.
Owing
to
synergy
between
heterostructures,
this
rationally
designed
BPNzyme
exhibits
significantly
enhanced
characteristics,
including
near‐infrared
(NIR)
photothermal
effect,
peroxidase‐like
glutathione
property,
which
can
effectively
reshape
tumor
microenvironment
disrupt
redox
homeostasis.
Under
action
TCM
β‐elemene
(β‐ELE)
NIR
light,
further
enhancement
oxidative
damage,
lipid
peroxidation,
peroxidase
4
expression
downregulation
are
observed
cells,
validating
synergistic
amplification
ferroptosis.
Moreover,
transdermal
delivery
β‐ELE
using
soluble
hyaluronic
acid
MN
achieves
99.8%
growth
suppression
without
systemic
toxicity
in
vivo.
These
findings
highlight
potential
BPNzyme‐based
system
as
promising
innovative
non‐invasive,
efficient,
safe
combination
melanoma.
Advanced Functional Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 27, 2024
Abstract
Interest
in
therapies
that
influence
cell
senescence
to
regulate
cancer
is
increasing.
However,
the
understanding
of
prolonged
state
senescent
cells
and
interactions
involved
when
utilizing
promote
alongside
other
techniques
suppress
progression
limited.
This
study
introduces
an
innovative
artificial
nanozyme
named
MVPR,
constructed
from
vanadium
MXene
(Mo
4
VC
)
combined
with
cyclin‐dependent
kinase
inhibitors
Palbociclib
Arg‐Gly‐Asp,
for
precise
targeting
membranes.
Within
tumor
environment,
MVPR
initiates
a
cascade
catalytic
reactions,
boosting
glutathione
consumption,
generating
reactive
oxygen
species
(ROS).
When
damage
ROS
exceeds
cellular
repair
capabilities,
redox
balance
disrupted,
resulting
apoptosis.
Alternatively,
can
be
triggered
under
different
circumstances.
Senescent
impede
their
own
nearby
growth
by
releasing
cytokines,
thereby
effectively
curtail
uncontrolled
proliferation.
Furthermore,
immune
response
recruitment
evoked
metal
ions
together
enhance
immunotherapeutic
effect,
system
activity
augmenting
CD4
+
/CD8
T
Cancer
are
eliminated
through
actions
pro‐senescence,
enzyme
catalysis,
immunogenic
response.
proposes
pro‐senescence
strategy
anti‐tumor
therapy.